<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9010">
 <list list-type="bullet">
  <list-item>
   <p id="Par495">The pre-AIDS era
    <list list-type="bullet">
     <list-item>
      <p id="Par496">Impaired vision
       <list list-type="bullet">
        <list-item>
         <p id="Par497">homonymous hemianopsia</p>
        </list-item>
       </list>
      </p>
     </list-item>
     <list-item>
      <p id="Par498">Motor weakness
       <list list-type="bullet">
        <list-item>
         <p id="Par499">hemiparesis or hemiplegia</p>
        </list-item>
       </list>
      </p>
     </list-item>
     <list-item>
      <p id="Par500">Changes in mentation:
       <list list-type="bullet">
        <list-item>
         <p id="Par501">personality change</p>
        </list-item>
        <list-item>
         <p id="Par502">difficulty with memory</p>
        </list-item>
        <list-item>
         <p id="Par503">emotional lability</p>
        </list-item>
        <list-item>
         <p id="Par504">dementia</p>
        </list-item>
       </list>
      </p>
     </list-item>
    </list>
   </p>
  </list-item>
  <list-item>
   <p id="Par505">AIDS-related PML
    <list list-type="bullet">
     <list-item>
      <p id="Par506">weakness (42%)</p>
     </list-item>
     <list-item>
      <p id="Par507">speech abnormalities (40%)</p>
     </list-item>
     <list-item>
      <p id="Par508">cognitive abnormalities (36%)</p>
     </list-item>
     <list-item>
      <p id="Par509">gait abnormalities (29%)</p>
     </list-item>
     <list-item>
      <p id="Par510">sensory loss (19%)</p>
     </list-item>
     <list-item>
      <p id="Par511">visual impairment (19%)</p>
     </list-item>
     <list-item>
      <p id="Par512">seizures</p>
     </list-item>
     <list-item>
      <p id="Par513">diplopia</p>
     </list-item>
     <list-item>
      <p id="Par514">limb incoordination</p>
     </list-item>
    </list>
   </p>
  </list-item>
  <list-item>
   <p id="Par515">PML associated with monoclonal antibody therapy
    <list list-type="bullet">
     <list-item>
      <p id="Par516">cognitive disorders (48%)</p>
     </list-item>
     <list-item>
      <p id="Par517">motor abnormalities (37%)</p>
     </list-item>
     <list-item>
      <p id="Par518">language disturbances (31%)</p>
     </list-item>
     <list-item>
      <p id="Par519">visual defects (26%)</p>
     </list-item>
    </list>
   </p>
  </list-item>
  <list-item>
   <p id="Par520">PMLâ€“IRIS immune reconstitution inflammatory syndrome
    <list list-type="bullet">
     <list-item>
      <p id="Par521">Paradoxical worsening of clinical or radiographic finding with recovery of the immune system</p>
     </list-item>
     <list-item>
      <p id="Par522">New or increased neurologic deficits</p>
     </list-item>
     <list-item>
      <p id="Par523">Increase in the number or size of lesions on neuroimaging</p>
     </list-item>
     <list-item>
      <p id="Par524">Contrast enhancement of brain lesions</p>
     </list-item>
     <list-item>
      <p id="Par525">Brain edema</p>
     </list-item>
     <list-item>
      <p id="Par526">Concurrent with diagnosis of PML</p>
     </list-item>
    </list>
   </p>
  </list-item>
 </list>
</p>
